SCHEMBL2442756

SCHEMBL2442756

COc1ncc(/C=N\O)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
CYP1A2 P05177 3/20 0.52
CYP3A4 P08684 3/20 0.52
CYP2C19 P33261 3/20 0.52
PKM P14618 1/20 0.52
HSD17B10 Q99714 2/20 0.49
HTT P42858 3/20 0.48
KMT2A Q03164 7/20 0.43
MEN1 O00255 6/20 0.43
MAPT P10636 4/20 0.43
HPGD P15428 3/20 0.43
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
NFKB1 P19838 3/20 0.43
NFKB2 Q00653 3/20 0.43
RELA Q04206 3/20 0.43
LMNA P02545 3/20 0.42
MAPK1 P28482 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2442757 1.00 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL27392980 0.77 LMNA (0.38) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL29768993 0.77 LMNA (0.38) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL22056621 0.77 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL29566288 0.77 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP2C19KMT2AMEN1
SCHEMBL9510001 0.77 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP2C19KMT2AMEN1
SCHEMBL13859011 0.77 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL13859010 0.77 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL30390367 0.76 KDM4E (0.44) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL27392988 0.75 ALDH1A1 (0.32) ALDH1A1CYP1A2CYP3A4CYP2C19PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed